Synvect is a biotechnology startup committed to eliminating vector-borne diseases through scalable, precision-driven mosquito suppression technology. Founded by scientists from UC San Diego, Synvect leverages CRISPR innovations to provide a safe, effective alternative to chemical pesticides.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/13/25 | $3,000,000 | Seed |
Antler Bill & Melinda Gates Foundation NuFund Venture Redbud | undisclosed |
